2N Pharma logo — 2N Pharma is a small biotech company with a big vision: we w...

2N Pharma

2N Pharma is a small biotech company with a big vision: we want to cure ALS and other brain diseases.

Founded 2019 Denmark Denmark 9 employees Biotechnology, Pharmaceutical

General Information

Company Name 2N Pharma
Founded Year 2019
Location Denmark Denmark
Employees 9
Industries Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with 2N Pharma. To contact 2N Pharma, visit 2npharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 2N Pharma compare?

A PDF of 2N Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 2N Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 2N Pharma

2N Pharma is a biotech company founded in 2019 and headquartered in Denmark. The company is driven by a bold vision of curing ALS and other brain diseases, seeking to bring about a paradigm shift in understanding the etiology and development of these debilitating conditions. 2N Pharma's innovative approach is grounded in a decade of research that has identified a shared pathogenic mechanism for various neurological disorders. The company aims to leverage this knowledge to develop groundbreaking drugs that can positively impact the lives of patients suffering from ALS and related conditions. Although details about the latest investment and investors are currently unavailable, 2N Pharma's ambitious mission and promising research place it as an intriguing prospect for potential venture capital consideration.

Business keywords: Biotech, Neurological Disorders, ALS Research, Drug Development, Small Molecule Therapies, Neuroscience, Biomedical Innovation, Research Translation, Funding, University Spin-off, Novel Therapies, Institutional Support, Scientific Leadership, Disease-modifying Drugs

No funding data available for 2N Pharma yet.

2N Pharma Alternatives & Competitors

View All Alternatives
2N Pharma vs
XWPharma
XWPharma United States

Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and other underserved CNS...

Series C
16 employees
Biotechnology, Health Care
2N Pharma vs

Towards an efficacious and well-tolerated appetite-suppressant using our innovative in-vivo screenin...

Seed
6 employees
Biotechnology, Health Care
2N Pharma vs
Emalex Biosciences
Emalex Biosciences United States

Improving people's lives impacted by central nervous system disorders through meaningful scientific...

Series D
54 employees
Biopharma, Biotechnology

FAQ About 2N Pharma

2N Pharma is a small biotech company with a big vision: we want to cure ALS and other brain diseases.
2N Pharma was founded in 2019.
2N Pharma is headquartered in Denmark.
2N Pharma operates in Biotechnology and Pharmaceutical. Its work centres on Biotech, Neurological Disorders, ALS Research and Drug Development.
2N Pharma has approximately 9 employees.
Top alternatives and competitors to 2N Pharma include XWPharma, EraCal Therapeutics , Emalex Biosciences, Ambrosia Biosciences Inc., Altay Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
2N Pharma and XWPharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 2N Pharma, https://bouncewatch.com/company/2n-pharma, updated 11 May 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes